Granov D A, Borovik V V, Polysalov V N
Central Research Institute of Roentgeno-Radiology, Ministry of Health of the RF, St. Petersburg.
Vopr Onkol. 2003;49(5):585-8.
The data on the treatment of colorectal carcinoma and synchronous metastatic involvement of the liver in 41 patients are presented. After extensive resections, complications were reported in 45.5%, partial--12%. Post-operative mortality was 4.9%. Relapse-free survival in group 1 was 8.9 +/- 2.7 months, group 2-9.7 +/- 3.1 months. Hepatic tumor progression within 3.5-39 months (9.1 +/- 2.4 months) was registered in 73.2%. Average survival in patients who had single-stage surgery was 23.1 months, after metachronous operations--23.7 months. Five-year survival rate was 12.1%.
本文呈现了41例结直肠癌伴肝脏同步转移患者的治疗数据。广泛切除术后，45.5%的患者出现并发症，部分切除术后为12%。术后死亡率为4.9%。第1组无复发生存期为8.9±2.7个月，第2组为9.7±3.1个月。73.2%的患者在3.5 - 39个月（9.1±2.4个月）内出现肝肿瘤进展。接受一期手术患者的平均生存期为23.1个月，异时手术患者为23.7个月。五年生存率为12.1%。
